EntSun News
 

Cancer News

10090497
FARGO, N.D. - Oct. 24, 2017 - -- Aldevron, a global provider of plasmid DNA and gene editing enzymes used to support novel cancer therapies, will be a Platinum sponsor of the 2017 Believe Ball organized by the Emily Whitehead Foundation. In its...
Provocative Book Reveals Widespread Abuse of Cancer Patients' Rights
FARMINGDALE, N.Y. - Oct. 5, 2017 - -- The Island Coffee Co. is excited to announce that from October through December 2017, they will be supplying their customers with a limited edition "pink" Island Coffee cup to build awareness for Breast Cancer...
LONDON - Aug. 24, 2017 - -- SMi Group has announced that Johnathan Zalevsky, Senior Vice President Biology & Preclinical Development, Nektar Therapeutics will be chairing day two of the 6th annual Cancer Vaccines conference, which will be taking...
SMi's 6th annual Cancer Vaccines event will showcase 3 key spotlight sessions on the latest advances in vaccine development and cancer therapy breakthroughs when it returns to Central London this autumn.
LAWRENCE, Mass. - May 9, 2017 - -- Commonwealth Motors was proud to host our 4th annual Buzz Off Bash for pediatric cancer. Our partnership with the One Mission organization has grown tremendously over our time and we have donated a grand total of...
Biosceptre's appointment of a CMO marks a major milestone in progression to the clinic of its therapeutic anticancer vaccine BIL06v against the novel oncology target nfP2X7.
METAvivor will train stage IV metastatic breast cancer patients and their supporters from across the US on advocacy issues affecting this community. Advocates will meet with Congressional leaders to request increased funding for research and improved...
IRVINE, Calif. - March 27, 2017 - -- The staggering cost of cancer treatment means only patients living in the wealthiest countries have access to the latest treatment options against cancer. Even among the most affluent countries like the US, many...
CAMBRIDGE, England - March 16, 2017 - -- Biosceptre's proposed Phase I clinical trial for BIL03s (anti-cancer monoclonal antibody therapy) was granted conditional approval by the Bellberry Ethics committee. Biosceptre is now seeking partners and...
METAvivor Research and Support, Inc. is requesting proposals for metastatic breast cancer research and has increased grant awards to $200,000 for this grant cycle. The organization has also included Young Investigator research awards in this year's...
The Discovery is Expected to Pave the Way for Metabolomics in the Monitoring and Treatment of Cancer
IRVINE, Calif. - Feb. 15, 2017 - -- HOPE BIOSCIENCES, INC. announced today that Dr. Michael Adam has joined the management team to oversee Pharmaceutical and Manufacturing Operations as well as Regulatory Affairs and Quality Assurance.
ASW '17 fundraising event exceeds goals in raising money for Face Off with Cancer, a nonprofit supporting cancer sufferers and their families.
Bioprognos obtains the CE Declaration of Conformity for its algorithm to support the diagnosis of lung cancer after complying with the requirements of the European directive on medical devices and implementing a quality management system according to...
Biosceptre is pleased to announce the appointment of its independent Director Sir Gregory Winter as the Chair of the Board of Directors.
Relaxing retreat for patients and caregivers affected by cancer is bringing big names, emotional stories, and great hope to a group of attendees from all across the country.
Relaxing retreat for patients and caregivers affected by cancer is bringing big names, emotional stories, and great hope to a group of attendees from all across the country.